Fundraising Fox
Perlara
YC W16San Francisco, US · Founded 2014 · Delaware corporation · 1 employees · 9 known investors
Find your way into Perlara
Sign up to see every warm intro you have to Perlara
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Perlara team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies. The company operates as a full-stack drug development platform serving rare disease patients and families.
Also known as Perlara PBC · Perlstein Lab PBC
Founders & leadership· Y Combinator alumni (W16)
Perlara was founded in 2014 by Ethan Perlstein.
Board
Investors · 9
How we know: the Y Combinator directory · funding news · press coverage · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 2 rounds · 2014–2017
▶$4.1MraisedAug 2017 · 21 investors · BiotechnologyRule 506(b)
- Ethan O PerlsteinExecutive Officer, Director, Promoter
- Matthew WilseyDirector
- Linda AveyDirector
- Offering amount
- $7.4M
- Amount sold
- $4.1M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$800KraisedMay 2014 · 2 investors · BiotechnologyRule 506(b)
- Ethan O PerlsteinExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $800K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
The YC application· Winter 2016 batch
Related companies · 3
Companies working in the same space as Perlara.
Legal entities · 2
corporate structureIn the news
Frequently asked questions
- What does Perlara do?
- Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies. The company operates as a full-stack drug development platform serving rare disease patients and families.
- Who founded Perlara?
- Perlara was founded by Ethan Perlstein in 2014.
- Who are Perlara's investors?
- Perlara's investors include Y Combinator, Agrolimen Ventures, Haystack, Homebrew, Lemonade Capital, MicroVentures, Novartis Institute for Biomedical Research, Radical Investments and 1 more.
- How much funding has Perlara raised?
- Perlara has disclosed $4.9M raised across 2 rounds.
- Where is Perlara headquartered?
- Perlara is headquartered in San Francisco, US.